After-hours movers: ContextLogic gains on buyback, CSX up on EPS

Go back to After-hours movers: ContextLogic gains on buyback, CSX up on EPS

EyePoint Pharmaceuticals (EYPT) shares surge as Baird says there are 'multiple catalysts ahead'

April 21, 2023 1:50 PM EDT

EyePoint Pharmaceuticals (NASDAQ: EYPT) was initiated with an Outperform rating and $33 per share price target at Baird on Friday, pushing its share price significantly higher.

The stock hit a high of over $10 per share following the upgrade. At the time of writing, it is... More

EyePoint Pharmaceuticals (EYPT) Halted on Volatility, Up 67%

April 21, 2023 10:19 AM EDT

EyePoint Pharmaceuticals (NASDAQ: EYPT) Halted on Volatility, Up 67%

... More

EyePoint Pharmaceuticals (EYPT) Climbs 38% Following Outperform Rating

April 21, 2023 10:15 AM EDT

EyePoint Pharmaceuticals (NASDAQ: EYPT) Climbs 38% Following Outperform Rating

Earlier Baird initiates coverage on EyePoint Pharmaceuticals with a Outperform rating and a price target of $33.00.... More

XPO Logistics' (XPO) new hires has Wall Street cheering and bulls pouncing

April 21, 2023 8:58 AM EDT

XPO Logistics (NYSE: XPO) stock gained 18% on Thursday after naming former Old Dominion executive Dave Bates as its COO. Despite the big jump, several analysts see the stock continuing higher with one analyst commenting today "If You Cant Beat Them, Hire Them."

Analysts at both Citi and JP Morgan upgraded shares to Buy Friday, with others lifting their price targets.

"We are upgrading shares of XPO to Buy from Neutral for a number of reasons catalyzed by the recent addition of... More